Policy Indications: COVID-19: UNICEF continues to ship vital supplies to affected countries   |  International Edu News: WHO Director-General calls on G20 to Fight, Unite, and Ignite against COVID-19  |  Education Information: WHO WhatsApp health alert launches in Arabic, French and Spanish  |  National Edu News: SJVN provides Rs 1 Cr for buying ventilators  |  Science Innovations: DST launches nationwide exercise to map & boost Covid19 solutions   |  National Edu News: Officers and staff of MNRE working from Home through e-office platform  |  National Edu News: Doordarshan to bring back famed Ramayan on Doordarshan National  |  Best Practices: Post Offices provide basic postal and financial services during COVID-19 lockdown  |  Leadership Instincts: Covid-19: Minister directs Kendriya Vidyalaya Sangathan to provide buildings   |  Education Information: National Testing Agency Postpones NEET UG May-2020  |  Leadership Instincts: Fight Corona IDEAthon   |  International Edu News: UK PM Boris Johnson tests positive for coronavirus  |  International Edu News: New mathematical model to track epidemics  |  International Edu News: Low risk of coronavirus spreading through tears  |  Teacher Insights: Language test for people with Fragile X syndrome  |  
March 23, 2020 Monday 10:09:28 AM IST

Proposals invited on COVID-19 & related respiratory viral infections

Science Innovations

COVID-19 virus has spread rapidly throughout the world. Given the lack of an efficacious vaccine and lack of availability of suitable chemotherapeutic interventions, the global population has been hit hard to the current coronavirus outbreak.

Science & Engineering Research Board (SERB), an autonomous institution of the Department of Science & Technology, invites proposals as part of special call under IRHPA (Intensification of Research in High Priority Area) scheme specifically designed for COVID-19 and related respiratory viral infections to ramp up national R&D efforts for new antivirals, vaccines, and affordable diagnostics.

Academic and research institutions have been encouraged to submit competitive proposals having a strong interdisciplinary component between chemists, biologists, virologists, immunologists, and clinicians, in the related areas and to focus on the development of affordable diagnostics, vaccines, antivirals, disease models and other R&D to study these infections.

One of the participating institutions should have access to BSL-3 (Bio-safety level 3) and above facilities, along with the expertise of handling respiratory viruses as per WHO/Govt. of India protocols.


DST-SERB encourages technical partnerships and collaborative know-how from biotech and pharmaceutical companies. SERB is committed for strategic investments to accelerate antiviral research.

The Proposals may be submitted as per SERB-IRHPA format by 5 pm on Monday the 30th March 2020, through the SERB online portal.

The proposals may focus on some of the key themes such as-

New or repurposed antivirals against valid viral targets; viricidal coatings; etc.


Affordable diagnostics for symptomatic and asymptomatic respiratory viral infections

Investigational vaccines against respiratory viruses

Response of virus to temperature, humidity & UV radiation

Development of disease models for respiratory viral infections


Studies on immune response and immunity during respiratory viral infections

Epidemiology of COVID-19 and other respiratory viral infections

(For further details, please visit: http://www.serb.gov.in/home.php)


Comments